CLTS OTC
Earth Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.4%
5Y: -97.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
+14.5% ▲
Net Income
-$2M
+13.1% ▲
EPS (Diluted)
$-0.00
+23.8% ▲
EBITDA
$0
+14.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $490 | $490 | $490 | $0 | $0 |
| Gross Profit | -$490 | -$490 | -$490 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38K | $438K | $53K | $2M | $2M |
| Operating Expenses | $38K | $438K | $54K | $2M | $2M |
| Operating Income | -$39K | -$438K | -$54K | -$2M | -$2M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $22K |
| Income Before Tax | -$7M | -$438K | -$54K | -$2M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7M | -$438K | -$54K | -$2M | -$2M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.03 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$7M | -$438K | -$53K | -$2M | $0 |
| Shares Outstanding | 271M | 333M | 333M | 438M | 495M |